logo
logo

Forbion invests USD 2.3M in seed financing of CoviCept Therapeutics, Inc.

Jan 19, 2021•over 4 years ago

Amount Raised

$2 Million

Round Type

seed

West Palm BeachVenture CapitalLife ScienceBiotechnology

Description

Forbion, a leading European life sciences venture capital firm, today announces a $2.3m seed investment in newly formed CoviCept Therapeutics, Inc. (“CoviCept”), a California-based company that is developing a small molecule that inhibits the replication of SARS-CoV-2 (COVID-19) and other RNA viruses.

Company Information

Company

Forbion

Location

West Palm Beach, Florida, United States

About

With approximately €3 billion in assets under management, Forbion provides capital and expertise to life sciences companies, enabling the development of new therapeutics that can impact the future of medicine. Forbion is a leading pan-European venture capital and growth equity firm focused on investing in high-quality life sciences companies across all stages of their development. Forbion Forbion is a dedicated life sciences venture capital firm with offices in The Netherlands, Germany, and Singapore.

Related People